Frederick G. Vogt - 03 Sep 2024 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Interim CEO & General Counsel, Director
Signature
/s/ Frederick G. Vogt
Issuer symbol
IOVA
Transactions as of
03 Sep 2024
Net transactions value
-$264,078
Form type
4
Filing time
05 Sep 2024, 19:56:04 UTC
Previous filing
17 Jul 2024
Next filing
16 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Options Exercise $0 +10,417 +6.5% $0.000000 169,726 03 Sep 2024 Direct F1
transaction IOVA Common Stock Tax liability $48,022 -4,426 -2.6% $10.85 165,300 03 Sep 2024 Direct F2, F3
transaction IOVA Common Stock Options Exercise $0 +46,875 +28% $0.000000 212,175 03 Sep 2024 Direct F1
transaction IOVA Common Stock Tax liability $216,056 -19,913 -9.4% $10.85 192,262 03 Sep 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IOVA Restricted Stock Units Options Exercise $0 -10,417 -14% $0.000000 62,504 03 Sep 2024 Common stock 10,417 Direct F4, F5, F6
transaction IOVA Restricted Stock Units Options Exercise $0 -46,875 -50% $0.000000 46,875 03 Sep 2024 Common Stock 46,875 Direct F4, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date.
F2 Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities.
F3 Represents common stock remaining after deducting the common stock withheld for taxes.
F4 Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F5 The remaining RSUs will vest in equal quarterly installments.
F6 Such aggregate number reflects the remainder of such RSUs granted on March 2, 2023, but does not include any other RSUs held by such Reporting Person.
F7 The remaining RSUs will vest on the one-year anniversary of the initial grant date, as provided in footnote 8.
F8 Such aggregate number reflects the remainder of such RSUs granted on March 1, 2024, but does not include any other RSUs held by such Reporting Person.